0001104659-26-075732.txt : 20260618 0001104659-26-075732.hdr.sgml : 20260618 20260618161513 ACCESSION NUMBER: 0001104659-26-075732 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260618 DATE AS OF CHANGE: 20260618 EFFECTIVENESS DATE: 20260618 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Liminatus Pharma, Inc. CENTRAL INDEX KEY: 0001971387 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-587962 FILM NUMBER: 261102734 BUSINESS ADDRESS: STREET 1: 12611 HIDDENCREEK WAY STREET 2: UNIT C CITY: CERRITOS STATE: CA ZIP: 90703 BUSINESS PHONE: 213-273-5453 MAIL ADDRESS: STREET 1: 12611 HIDDENCREEK WAY STREET 2: UNIT C CITY: CERRITOS STATE: CA ZIP: 90703 FORMER COMPANY: FORMER CONFORMED NAME: Iris Parent Holding Corp. DATE OF NAME CHANGE: 20230328 D 1 primary_doc.xml X0708 D LIVE 0001971387 Liminatus Pharma, Inc. 2251 STERN GOODMAN STREET, SUITE E FULLERTON CA CALIFORNIA 92833 213-273-5453 DELAWARE None Iris Parent Holding Corp. Corporation true Chris Kim 2251 Stern Goodman Street, Suite E Fullerton CA CALIFORNIA 92833 Executive Officer Director Scott Dam 2251 Stern Goodman Street, Suite E Fullerton CA CALIFORNIA 92833 Executive Officer Byong C. Yoo 2251 Stern Goodman Street, Suite E Fullerton CA CALIFORNIA 92833 Executive Officer Sang-jin Daniel Lee 2251 Stern Goodman Street, Suite E Fullerton CA CALIFORNIA 92833 Executive Officer Beom K. Choi 2251 Stern Goodman Street, Suite E Fullerton CA CALIFORNIA 92833 Executive Officer Eun Sook Lee 2251 Stern Goodman Street, Suite E Fullerton CA CALIFORNIA 92833 Director Nicholas Fernandez 2251 Stern Goodman Street, Suite E Fullerton CA CALIFORNIA 92833 Director Ji Yeon Baek 2251 Stern Goodman Street, Suite E Fullerton CA CALIFORNIA 92833 Director Pharmaceuticals Decline to Disclose 06b false 2026-06-03 false true true false 0 Maxim Group LLC 000120708 None None 300 PARK AVE 16TH FLOOR NEW YORK NY NEW YORK 10022 NY NEW YORK false 1861920 1861920 0 false 1 148954 0 0 false Liminatus Pharma, Inc. /s/ Chris Kim Chris Kim Chief Executive Officer 2026-06-18